Showing results (11-20 of 104) with videos related to

Sort By:
Pageof 11
European Journal of Nuclear Medicine and Molecular Imaging|January 10, 2015
Image-derived biomarkers and multimodal imaging strategies for lung cancer managementAlexander W Sauter, Nina Schwenzer, Mathew R Divine, et al.
European Journal of Radiology|December 4, 2014
Is the standard uptake value (SUV) appropriate for quantification in clinical PET imaging? - Variability induced by different SUV measurements and varying reconstruction methodsCornelia Brendle, Jürgen Kupferschläger, Konstantin Nikolaou, et al.
Scientific Reports|December 14, 2020
Determinants of activity of brown adipose tissue in lymphoma patientsCornelia Brendle, Norbert Stefan, Eva Grams, et al.
European Journal of Radiology|January 12, 2020
Effects of simulated dose variation on contrast-enhanced CT-based radiomic analysis for Non-Small Cell Lung CancerTobias Hepp, Ahmed Othman, Annika Liebgott, et al.
Insights Into Imaging|May 23, 2019
State of affairs of hybrid imaging in Europe: two multi-national surveys from 2017Sergios Gatidis, Thomas Beyer, Minerva Becker, et al.
Investigative Radiology|June 4, 2015
Patient comfort during positron emission tomography/magnetic resonance and positron emission tomography/computed tomography examinations: subjective assessments with visual analog scalesBrigitte Gückel, Sergios Gatidis, Paul Enck, et al.
European Journal of Nuclear Medicine and Molecular Imaging|January 29, 2003
Improved detection of splenosis in patients with haematological disorders: the role of combined transmission-emission tomographyMarius Horger, Susanne Martina Eschmann, Claudia Lengerke, et al.
Frontiers in Oncology|July 19, 2021
<sup>18</sup>F-Fluoride PET/CT Imaging of Medication-Related Osteonecrosis of the Jaw in Conservative Treatment-A Case ReportChristian Philipp Reinert, Christina Pfannenberg, Sergios Gatidis, et al.
La Radiologia Medica|July 2, 2018
Fast non-enhanced abdominal examination protocols in PET/MRI for patients with neuroendocrine tumors (NET): comparison to multiphase contrast-enhanced PET/CTFerdinand Seith, Christina Schraml, Gerald Reischl, et al.
European Journal of Nuclear Medicine and Molecular Imaging|September 20, 2015
Influence of (18)F-FDG PET/CT on therapy management in patients with stage III/IV malignant melanomaSusann-Cathrin Schüle, Thomas Kurt Eigentler, Claus Garbe, et al.
Pageof 11